Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
Head & Neck2017Vol. 40(3), pp. 605–613
Citations Over TimeTop 1% of 2017 papers
Eline Boon, Wim van Boxtel, Jan Buter, Robert J. Baatenburg de Jong, Robert J.J. van Es, Miranda Bel, E. Fiets, Sjoukje F. Oosting, Marije Slingerland, Ann Hoeben, Margot Tesselaar, Marianne A. Jonker, Uta Flucke, Nationwide Network and Registry of Histopathology and Cytopathology (PALGA) Group, Winette T.A. van der Graaf, Carla M.L. van Herpen
Abstract
We recommend ADT in advanced androgen receptor-positive salivary duct carcinoma given its response and clinical benefit. © 2017 Wiley Periodicals, Inc. Head Neck, 2017.
Related Papers
- → Homologous Androgen Receptor Up-Regulation in Osteoblastic Cells May Be Associated with Enhanced Functional Androgen Responsiveness*(1999)33 cited
- → Cytologic features of salivary duct carcinoma. The significance of androgen receptor immunostaining.(2001)1 cited
- → Androgen receptor: role in the female lower vertebrate reproduction(2010)
- Advances in Effects of Androgen on Androgen Receptors(2001)
- → THE PHYSIOPATHOLOGICAL ROLES OF ANDROGENS IN MOTONEURONS(2020)